A preparation method of 4H-pyrido[1,2-a]pyrimidin-4-one compound
By optimizing the preparation method of 4H-pyridino[1,2-a]pyrimidin-4-one, the reaction chains of compounds a and e are used, combined with acidic conditions, the long reflux time, low yield and environmental protection in the prior art are solved. The problem of poor performance achieves efficient and low-cost preparation and is suitable for industrial production.
Patent Information
- Application Number
- CN202210015633.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2021-01-08
- Filing Date
- 2022-01-07
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2042-01-07
AI Technical Summary
The existing preparation method of 4H-pyridino[1,2-a]pyrimidin-4-one has long reflux time, difficulty in industrialization of microwave reactions, low yields, and the solvents and raw materials used are not conducive to industrial production, especially trifluoro The problem of poor environmental protection of acetic acid and high raw material prices.
The step of using the reaction of compounds a and e to obtain b, b and f to obtain c, c further reacting in the presence of acid to obtain d, using preferred organic solvents and alkali or acid conditions to control the reaction temperature and time, and improve the total yield and economical.
It realizes a simple, efficient and low-cost preparation method, improves the total yield, is suitable for industrial production, reduces raw material costs, and improves environmental protection.
Smart Images

Figure CN114751902B_ABST
Abstract
Description
Technical Field
[0001] The present application belongs to the field of drug synthesis and relates to a method for preparing a 4H-pyrido[1,2-a]pyrimidin-4-one compound. Technical Background
[0002] PI3K kinase (phosphatidylinositol 3-kinase, PI3Ks) belongs to the lipid kinase family and can phosphorylate the 3'-OH end of the inositol ring of phosphatidylinositol. Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase composed of regulatory subunits p85 or p101 and catalytic subunits p110. It activates downstream Akt and other proteins by catalyzing the phosphorylation of phosphatidylinositol 4,5-bisphosphate (phosphatidylinositol 4,5-bisphosphate, PIP2) to phosphatidylinositol 3,4,5-trisphosphate (phosphatidylinositol 3,4,5-trisphosphate, PIP3), thereby playing a key role in cell proliferation, survival and metabolism. Therefore, inhibiting phosphatidylinositol 3-kinase can affect the PI3K pathway, thereby inhibiting the proliferation and activation of cancer cells.
[0003] The reported PI3K kinase inhibitors contain a 4H-pyrido[1,2-a]pyrimidin-4-one structure, so a method for preparing 4H-pyrido[1,2-a]pyrimidin-4-one is needed.
[0004] WO2015192760 discloses the following route, using ethyl glycolate as a raw material, protecting the hydroxyl group with tert-butyldimethylsilyl chloride (TBSCl), and then reacting with N,N,N',N'-tetramethyldiaminomethane to obtain intermediate 2, intermediate 2 is replaced by 2-amino-5-bromopyridine to obtain intermediate 3, and intermediate 3 is cyclized under microwave conditions to obtain the target compound.
[0005]
[0006] In this route, the step of preparing intermediate 2 requires a long reflux time; the microwave reaction required to prepare the target product is difficult to apply to industrial production; the reaction yield is low, and the total yield of the four-step reaction is about 19.5%.
[0007] In the route disclosed in WO2017101829, 2-benzyloxyacetyl chloride is used as a raw material, and the target is prepared by a four-step reaction with a total yield of about 56.8%. Although the total yield of the preparation process is nearly 3 times higher than that of the method disclosed in WO2015192760, there is still a great demand for improvement. In addition, the solvent trifluoroacetic acid used in the preparation of the target has poor environmental protection, making it unfavorable for industrial production; the raw material 2-benzyloxyacetyl chloride and the tert-butoxybis(dimethylamino)methane used to prepare intermediate 2 are expensive and have poor economic efficiency.
[0008]
[0009] The preparation method disclosed in WO2015192761 involves the preparation of the compound 7-bromo-3-methoxy-4H-pyrido[1,2-a]pyrimidin-4-one, specifically, using ethyl 2-methoxyacetate as a raw material, and obtaining the target product through two-step reaction, the yields of step a) and step b) are 67.8% and 35.1% respectively, wherein the yield of step b) is relatively low. If the compound 7-bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one is prepared by this method, the total yield is relatively low.
[0010]
[0011] Therefore, there is a need in the art to develop a new, simple, efficient, low-cost, high-yield preparation method that can be used in industrial production. Summary of the invention
[0012] In one aspect, the present application provides a method for preparing a compound of formula c, comprising the step (ii) of obtaining a compound of formula c by reacting a compound of formula b with a compound of formula f:
[0013]
[0014] Among them, the R 1 , R 2 and R 3 Each independently selected from C1-C4 alkyl;
[0015] The X is selected from halogen.
[0016] In some embodiments, the method for preparing a compound of formula c further comprises the step (i) of reacting a compound of formula a with a compound of formula e to obtain a compound of formula b:
[0017]
[0018] Among them, the R 1 , R 2 and R 3Each is independently selected from C1-C4 alkyl.
[0019] On the other hand, the present application provides a method for preparing a compound of formula d, comprising step (ii) of reacting a compound of formula b and a compound of formula f to obtain a compound of formula c and step (iii) of reacting the compound of formula c to obtain a compound of formula d:
[0020]
[0021] Among them, the R 1 , R 2 and R 3 Each independently selected from C1-C4 alkyl;
[0022] The X is selected from halogen.
[0023] In some embodiments, the method for preparing the compound of formula d further comprises the step (i) of reacting the compound of formula a and the compound of formula e to obtain the compound of formula b:
[0024]
[0025] Among them, the R 1 , R 2 and R 3 Each is independently selected from C1-C4 alkyl.
[0026] In some embodiments, the R 1 , R 2 and R 3 Each is independently selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, iso-n-butyl, or tert-butyl; preferably, the R 1 , R 2 and R 3 Each is independently selected from methyl or ethyl; More preferably, the R 1 , R 2 and R 3 Each independently selects a methyl group.
[0027] In some embodiments, the X is selected from F, Cl, Br, or I; preferably, the X is selected from Cl, or Br; more preferably, the X is selected from Br.
[0028] In some embodiments, step (i) is carried out in an organic solvent. In some embodiments, in step (i), the organic solvent is selected from any one or a combination of two or more of tetrahydrofuran, 2-methyltetrahydrofuran, dimethyl sulfoxide, dioxane, toluene, acetone, cyclohexanone, dichloromethane, or dimethylformamide; preferably tetrahydrofuran.
[0029] In some embodiments, the step (i) is carried out in the presence of a base. In some embodiments, in step (i), the base is selected from NaH, t-BuOK, t-BuONa, LDA, or LiHMDS; preferably NaH, t-BuOK, or t-BuONa; most preferably NaH or t-BuOK.
[0030] In some embodiments, the reaction temperature in step (i) is 10-60°C; preferably 10-40°C; more preferably 20-30°C.
[0031] In some embodiments, the reaction time in step (i) is 12-24 h; preferably 12-16 h.
[0032] In some embodiments, in step (i), the compound of formula a and the compound of formula e are first dissolved in an organic solvent at low temperature, and then a base is added and the temperature is raised to react; preferably, the low temperature is -5-5°C.
[0033] In some embodiments, in step (i), the molar ratio of the compound of formula a to the compound of formula e is 1:1-10; preferably 1:1-5; more preferably 1:1-2; further preferably 1:1-1.2; most preferably 1:1.2.
[0034] In some embodiments, in step (i), the molar ratio of the compound of formula a to the base is 1:1-15; preferably 1:1-10; more preferably 1:1-5; further preferably 1:1-2; further preferably 1:1-1.4; most preferably 1:1.4.
[0035] In some embodiments, the step (ii) is carried out in the presence of an acid, the acid being present in the form of, but not limited to, a reagent or a solvent. In some embodiments, in step (ii), the acid is selected from formic acid, acetic acid, propionic acid, butyric acid, trifluoroacetic acid, methanesulfonic acid, benzenesulfonic acid, or p-toluenesulfonic acid; preferably, the acid is selected from acetic acid, trifluoroacetic acid, methanesulfonic acid, or benzenesulfonic acid; more preferably, the acid is selected from acetic acid.
[0036] In some embodiments, the step (ii) is performed in an acidic solution. In some embodiments, the acidic solution is selected from acetic acid, a methanol solution of acetic acid, an ethanol solution of acetic acid, a propanol solution of acetic acid, a butanol solution of acetic acid, trifluoroacetic acid, methanesulfonic acid, or benzenesulfonic acid; preferably acetic acid, or an ethanol solution of acetic acid; more preferably acetic acid.
[0037] In some embodiments, in step (ii), the molar ratio of the compound of formula f to the compound of formula b is 1:1-15; preferably 1:1-10; more preferably 1:1-5; further preferably 1:1-2; further preferably 1:1-1.5.
[0038] In some embodiments, the reaction temperature of step (ii) is 80-150°C; preferably 100-150°C; more preferably 115-125°C.
[0039] In some embodiments, the reaction time of step (ii) is 2-10 h; preferably 5-6 h.
[0040] In some embodiments, step (iii) is carried out in the presence of an acid. In some embodiments, the acid is selected from a protic acid or a Lewis acid. In some embodiments, the acid is selected from HBr, BBr3, or AlCl3.
[0041] In some embodiments, step (iii) is performed in a solution of HBr in acetic acid; in some embodiments, a solution of HBr dissolved in acetic acid is added dropwise to the compound of formula c to react to obtain a compound of formula d.
[0042] In some embodiments, step (iii) is carried out in a solution of HBr in acetic acid at a reaction temperature of 80-150°C; preferably 95-100°C.
[0043] In some embodiments, step (iii) is performed in a DCM solution of BBr3; in some embodiments, the compound of formula c is dissolved in DCM, and a solution of BBr3 dissolved in DCM is added dropwise under nitrogen protection to prepare a compound of formula d.
[0044] In some embodiments, step (iii) is carried out in a solution of BBr3 in DCM at a reaction temperature of -10-30°C; preferably -10-0°C.
[0045] In some embodiments, step (iii) is carried out in the presence of AlCl3-NaI; in some embodiments, the steps include: adding the compound of formula c, AlCl3 and NaI to an organic solvent to react to prepare a compound of formula d; in some embodiments, the organic solvent is selected from dichloromethane, tetrahydrofuran, 2-methyltetrahydrofuran, dimethyl sulfoxide, dioxane, toluene, or acetone; preferably dichloromethane or tetrahydrofuran.
[0046] In some embodiments, step (iii) is carried out in the presence of AlCl3-NaI, and the reaction temperature is 0-120°C; preferably 20-60°C.
[0047] In some embodiments, step (iii) is carried out in the presence of AlCl3-NaI, and the reaction time is 2-18 h; preferably 3-12 h.
[0048] In some embodiments, step (iii) is carried out in the presence of AlCl3-NaI, and the molar ratio of the compound of formula c to AlCl3 is 1:1-5; preferably 1:1-1.5.
[0049] In some embodiments, step (iii) is carried out in the presence of AlCl3-NaI, and the molar ratio of AlCl3 to NaI is 1:0.4-2; preferably 1:0.6-1.
[0050] definition
[0051] Unless otherwise specified, the following terms used in this application have the following meanings. A particular term should not be considered to be uncertain or unclear in the absence of a special definition, but should be understood according to the common meaning in the art. When a trade name appears in this article, it is intended to refer to the corresponding commodity or its active ingredient.
[0052] NaH represents sodium hydride; t-BuOK represents potassium tert-butoxide; t-BuONa represents sodium tert-butoxide; LDA represents lithium diisopropylamide; LiHMDS represents lithium hexamethyldisilazide; BBr3 represents boron tribromide; AlCl3 represents aluminum trichloride; NaI represents sodium iodide; HBr represents hydrobromic acid; DCM represents dichloromethane; HPLC represents high performance liquid chromatography.
[0053] All solvents used in this application are commercially available and can be used without further purification. The reaction is generally carried out under inert nitrogen and in anhydrous solvents.
[0054] The preparation method of the present application has low cost and high yield, and can be used in industrial production. DETAILED DESCRIPTION
[0055] The following specific embodiments are intended to enable those skilled in the art to more clearly understand and implement the present invention. They should not be considered as limiting the scope of protection of the present invention, but are merely exemplary and typical representations of the present invention.
[0056] Example 1 Preparation of Compound 7-bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (d1)
[0057]
[0058] Synthesis of compound (Z)-2,3-dimethoxymethyl acrylate (b1)
[0059] Compound a1 (12.12 g, 115.2 mmol), methyl formate (8.74 g, 138.3 mmol) and tetrahydrofuran (500 mL) were mixed, replaced with nitrogen, cooled to -5 to 5°C until a colorless and clear system was obtained. t-BuOK (18.08 g, 161.2 mmol) was added, and the system was an off-white suspension; the temperature was raised to 20 to 30°C, stirred for reaction for more than 12 hours, water (500 mL) was added at 0 to 10°C and stirred for 30 minutes, ethyl acetate (1000 mL) was added for extraction, the aqueous phase was separated, and then extracted with ethyl acetate (500 mL), the organic phases were combined, washed with salt, dried, and concentrated to obtain 15.44 g of compound b1, with a yield of 91.7%.
[0060] Synthesis of compound 7-bromo-3-methoxy-4H-pyrido[1,2-a]pyrimidin-4-one (c1)
[0061] The compound of formula b1 (15.34 g, 105 mmol), 2-amino-5-bromopyridine (11.54 g, 66.7 mmol) and glacial acetic acid (460 mL) were mixed; after nitrogen replacement, the temperature was raised to 115-125° C., and the reaction was stirred for more than 5 h until the reaction of 2-amino-5-bromopyridine was completed (monitored by HPLC until the compound of formula c1 was >85%); the heating was stopped, the temperature was lowered to 55-65° C., and the concentrated solution was concentrated to dryness under reduced pressure at the same temperature to obtain a concentrate of the compound of formula c1; dichloromethane (460 mL) was added to the concentrate and stirred to dissolve, and an aqueous sodium carbonate solution (460 mL, 69 g of sodium carbonate was dissolved in 460 mL of water) was added and stirred for washing, and the organic phase was separated to obtain an organic phase, which was washed with saturated brine (600 mL); the organic phase was dried over anhydrous sodium sulfate, filtered, rinsed with dichloromethane, and the filtrate was concentrated at 25-35° C. to obtain a crude product of the compound of formula c1.
[0062] The crude product of the compound of formula c1 was added to 128 mL of isopropanol and stirred at 80-85°C to dissolve. The mixture was cooled to room temperature and stirred for crystallization for more than 1 h. The mixture was stirred at -5-5°C for crystallization for more than 5 h. The mixture was filtered and the wet product was dried under reduced pressure at 40-50°C to obtain 14.2 g of a light yellow to yellow solid. The yield of this step was 83.5%.
[0063] HRMS (ESI, [M+H] + )m / z:254.9764.
[0064] 1 H NMR (500MHz, DMSO-d6) δ8.88(d,J=1.9Hz,1H),8.19(s,1H),7.79(dd,J=9.5,2.2Hz,1H),7.54(d,J=9.5Hz,1H),3.89(s,3H).
[0065] 13C NMR (126MHz, DMSO-d6) δ152.01,143.74,139.91,135.86,134.85,127.62,125.71,110.00,57.06.
[0066] Synthesis of Compound 7-Bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (d1)
[0067] The compound of formula c1 (14 g, 54.9 mmol) was dissolved in tetrahydrofuran solution (140 mL), and aluminum chloride (11 g, 82.5 mmol) and sodium iodide (8.24 g, 55.0 mmol) were added, and the mixture was reacted at 60° C. for 3 h; water (140 mL) was added for washing, and the mixture was extracted with ethyl acetate (280 mL). The aqueous phase was separated, and the aqueous phase was extracted with ethyl acetate (140 mL). The organic phases were combined, washed with 5% aqueous sodium bicarbonate solution (200 mL) and saturated brine (200 mL), respectively, and dried and concentrated to obtain 12.02 g of the compound of formula d1. The yield of this step was 90.8%, and the total yield of the three steps was 69.5%.
[0068] HRMS (ESI, [M+H] + )m / z:240.9607.
[0069] 1 H NMR (500MHz, DMSO-d6) δ9.92(br.s.,1H),8.89(d,J=2.1Hz,1H),8.06(s,1H),7.73(dd,J=9.5,2.2Hz,1H),7.52(d,J=9.5Hz,1H).
[0070] 13 C NMR (126MHz, DMSO-d6) δ152.52,142.60,138.05,135.88,134.69,127.62,125.46,110.06.
[0071] Example 2 Preparation of (Z)-2,3-dimethoxymethyl acrylate (b1) under different conditions
[0072] Compound a1 (12.12 g, 115.2 mmol), methyl formate (8.74 g, 138.3 mmol) and tetrahydrofuran (500 mL) were mixed, replaced with nitrogen, cooled to -5 to 5°C, until a colorless and clear system was obtained; NaH (6.46 g, 60%, 161.5 mmol) was added in two batches, and the system was an off-white suspension; the temperature was raised to 20 to 30°C, and the reaction was stirred overnight. Methyl tert-butyl ether (1000 mL) was added and the mixture was beaten for more than 2 hours, and suction filtered (the filter cake is easy to absorb moisture, and no filtrate drips), and the filter cake was dried under reduced pressure at 25 to 35°C for more than 6 hours to obtain 17.6 g of off-white solid compound b1, with a yield of 105%. (The yield range is 100 to 120%, and it may contain sodium salt, etc.).
[0073] Example 3 Preparation of 7-bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (d1) by demethylation using HBr / acetic acid method
[0074] The compound of formula c1 (20 mg) was placed in a sealed tube, and an acetic acid solution of HBr (2 mL, 33% in acetic acid, v / v) was added. The mixture was reacted at 95-100°C (dissolved clearly, solid precipitated after cooling). The reaction was carried out for about 5.5 hours. The purity of the compound of formula d1 was 97.81% as determined by HPLC.
[0075] Example 4 Preparation of 7-bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (d1) by demethylation using HBr / acetic acid method
[0076] Take the compound of formula c1 (0.5 g) in a sealed tube, add HBr acetic acid solution (30 mL, 33% in acetic acid, v / v), react at 95-100°C (dissolves clearly at high temperature and then gradually becomes turbid), after reacting for 4.5 hours, HPLC detection of the purity of the compound of formula d1 is 95.92%, concentrate to dryness, and beat with ethyl acetate to obtain 590.5 mg of white solid.
[0077] Example 5 Preparation of 7-bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (d1) by demethylation using the BBr3 / DCM method
[0078] The compound of formula c1 (20 mg) was placed in a three-necked flask, and dichloromethane was added to dissolve, and the atmosphere was replaced with nitrogen, and stirred at -10 to 0°C. A dichloromethane solution of BBr3 (1 mol / L, 0.4 mL) was added dropwise, and stirred for about 1.5 h. The purity of the compound of formula d1 was 94.91% as determined by HPLC.
[0079] Example 6 Preparation of 7-bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (d1) by demethylation using the BBr3 / DCM method
[0080] The compound of formula c1 (0.5 g) was placed in a three-necked flask, and dichloromethane (15 mL) was added to stir and dissolve, and after nitrogen replacement, the mixture was stirred at -10 to 0°C. A dichloromethane solution of BBr3 (1 mol / L, 10 mL) was added dropwise, and after stirring for 4 h, the purity of the compound of formula d1 was 99.01% by HPLC.
[0081] Example 7 Preparation of 7-bromo-3-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (d1) by demethylation using the AlCl3-NaI method
[0082] Take the compound of formula c1 (0.5 g) and dissolve it in dichloromethane (5 mL). Then add AlCl3 (0.39 g) and NaI (0.29 g). First react at 0°C for 1 h, then react at 20-30°C for 2 h, stir overnight and then react for another 2 h. The purity of the compound of formula d1 detected by HPLC is 90%.
Claims
1. A method for preparing a compound of formula c, comprising the step (ii) of obtaining a compound of formula c by reacting a compound of formula b with a compound of formula f: in, The R 1 , R 2 and R 3 Each independently selected from C 1 -C 4 alkyl; The X is selected from halogen.
2. A method for preparing a compound of formula d, comprising step (ii) of reacting a compound of formula b with a compound of formula f to obtain a compound of formula c and step (iii) of reacting the compound of formula c to obtain a compound of formula d: in, The R 1 , R 2 and R 3 Each independently selected from C 1 -C 4 alkyl; The X is selected from halogen.
3. The preparation method according to claim 2, further comprising the step (i) of obtaining a compound of formula b by reacting a compound of formula a with a compound of formula e: in, The R 1 , R 2 and R 3 Each independently selected from C 1 -C 4 alkyl.
4. The preparation method according to any one of claims 1 to 3, wherein R 1 , R 2 and R 3 Each is independently selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, iso-n-butyl, or tert-butyl.
5. The preparation method according to claim 1 or 2, wherein X is selected from F, Cl, Br, or I.
6. The preparation method according to claim 3, wherein step (i) is carried out in an organic solvent, and the organic solvent is selected from any one of tetrahydrofuran, 2-methyltetrahydrofuran, dimethyl sulfoxide, dioxane, toluene, acetone, cyclohexanone, dichloromethane, or dimethylformamide, or a combination of two or more thereof.
7. The preparation method according to claim 3, wherein the step (i) is carried out in the presence of a base selected from NaH, t-BuOK, t-BuONa, LDA, or LiHMDS.
8. The preparation method according to claim 3, wherein the molar ratio of the compound of formula a to the compound of formula e is 1:1-10.
9. The preparation method according to claim 8, wherein the molar ratio of the compound of formula a to the compound of formula e is 1:1-5.
10. The preparation method according to claim 8, wherein the molar ratio of the compound of formula a to the compound of formula e is 1:1-2.
11. The preparation method according to claim 8, wherein the molar ratio of the compound of formula a to the compound of formula e is 1:1-1.
2.
12. The preparation method according to claim 8, wherein the molar ratio of the compound of formula a to the compound of formula e is 1:1.
2.
13. The preparation method according to claim 3, wherein the molar ratio of the compound of formula a to the base is 1:1-15.
14. The preparation method according to claim 13, wherein the molar ratio of the compound of formula a to the base is 1:1-10.
15. The preparation method according to claim 13, wherein the molar ratio of the compound of formula a to the base is 1:1-5.
16. The preparation method according to claim 13, wherein the molar ratio of the compound of formula a to the base is 1:1-2.
17. The preparation method according to claim 13, wherein the molar ratio of the compound of formula a to the base is 1:1-1.
4.
18. The preparation method according to claim 13, wherein the molar ratio of the compound of formula a to the base is 1:1.
4.
19. The preparation method according to any one of claims 1 to 3, wherein step (ii) is carried out in the presence of an acid selected from formic acid, acetic acid, propionic acid, butyric acid, trifluoroacetic acid, methanesulfonic acid, benzenesulfonic acid, or p-toluenesulfonic acid.
20. The preparation method according to any one of claims 1 to 3, wherein step (ii) is carried out in an acidic solution, and the acidic solution is selected from acetic acid, a methanol solution of acetic acid, an ethanol solution of acetic acid, a propanol solution of acetic acid, a butanol solution of acetic acid, trifluoroacetic acid, methanesulfonic acid, or benzenesulfonic acid.
21. The preparation method according to any one of claims 1 to 3, wherein in step (ii), the molar ratio of the compound of formula f to the compound of formula b is 1:1-15.
22. The preparation method according to claim 21, wherein in step (ii), the molar ratio of the compound of formula f to the compound of formula b is 1:1-10.
23. The preparation method according to claim 21, wherein in step (ii), the molar ratio of the compound of formula f to the compound of formula b is 1:1-5.
24. The preparation method according to claim 21, wherein in step (ii), the molar ratio of the compound of formula f to the compound of formula b is 1:1-2.
25. The preparation method according to claim 21, wherein in step (ii), the molar ratio of the compound of formula f to the compound of formula b is 1:1-1.
5.
26. The preparation method according to any one of claims 1 to 3, wherein the reaction temperature in step (ii) is 80-150°C.
27. The preparation method according to claim 26, wherein the reaction temperature of step (ii) is 100-150°C.
28. The preparation method according to claim 26, wherein the reaction temperature of step (ii) is 115-125°C.
29. The preparation method according to claim 2 or 3, wherein step (iii) is carried out in the presence of an acid selected from HBr, BBr 3 , or AlCl 3 .
30. The preparation method according to claim 2 or 3, wherein the step (iii) is carried out in an acetic acid solution of HBr at a reaction temperature of 80-150°C.
31. The preparation method according to claim 2 or 3, wherein the step (iii) is carried out in BBr 3 The reaction is carried out in a DCM solution at a temperature of -10-30°C.
32. The preparation method according to claim 2 or 3, wherein the step (iii) is carried out in AlCl 3 - in the presence of NaI.
33. The preparation method according to claim 32, wherein step (iii) include: Compound c is reacted with AlCl 3 and NaI are added to an organic solvent to react to prepare a compound of formula d, wherein the organic solvent is selected from dichloromethane, tetrahydrofuran, 2-methyltetrahydrofuran, dimethyl sulfoxide, dioxane, toluene, or acetone; the reaction temperature is 0-120°C; the compound of formula c is reacted with AlCl 3 The molar ratio of AlCl 3 The molar ratio of NH4Cl2 to NaI is 1:0.4-2.
